|
Match
|
Document |
Document Title |
|
|
US20150079137 |
EXOPOLYSACCHARIDE FOR THE TREATMENT AND/OR CARE OF THE SKIN, MUCOUS MEMBRANES AND/OR NAILS
Exopolysaccharide of a bacterial strain for its use in treatment and/or care of the skin, mucous membranes, hair and/or nails, as well as its cosmetic and/or dermopharmaceutical compositions. In... |
|
|
US20140242159 |
Method for Preparing a Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients
A capsule formulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. In one embodiment, this capsule formulation is capable of sustaining desirable... |
|
|
US20130202690 |
ENCAPSULATED PICOPLATIN
The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt %... |
|
|
US20150231086 |
TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS
Oral dosage forms containing an opioid antagonist in a sequestered form are described. The opioid antagonist is sequestered such that it is not released or substantially not released in the... |
|
|
US20150190344 |
FORMULATIONS FOR DELIVERING INSULIN
Oral insulin formulations and processes for preparing oral insulin formulations are provided. |
|
|
US20150071994 |
GASTROINTESTINAL SITE-SPECIFIC ORAL VACCINATION FORUMULATIONS ACTIVE ON THE ILEUM AND APPENDIX
The invention provides oral vaccine formulations which deliver an antigen in the vicinity of the distal ileum and the area of the ileal Brake and/or the appendix. These vaccines are useful in the... |
|
|
US20150182467 |
TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS
Methods of decreasing abuse potentials of oral opioid dosage forms are described. In the methods, an opioid antagonist in a substantially non-releasable form is included in oral dosage forms... |
|
|
US20130095177 |
METHOD OF PREPARING AN ORAL DOSAGE FORM COMPRISING FINGOLIMOD
The present invention relates to a method of preparing an intermediate containing fingolimod, a method of preparing granules containing fingolimod, a method of preparing an oral dosage form... |
|
|
US20120021051 |
ZALEPLON GASTRORETENTIVE DRUG DELIVERY SYSTEM
A biodegradable, multi-layered controlled release gastroretentive dosage form which is optionally divided into a first dosage of zaleplon for controlled release and a second dosage of zaleplon for... |
|
|
US20150216992 |
EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
The present invention relates to extended release compositions of an amino-C2-C6-alkyl nitrate and of pharmaceutically acceptable salt thereof, in particular 2-aminoethyl nitrate, and to fixed... |
|
|
US20140178467 |
CAPSULE AND POWDER FORMULATIONS CONTAINING LANTHANUM COMPOUNDS
The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates... |
|
|
US20120141581 |
CAPSULE AND POWDER FORMULATIONS CONTAINING LANTHANUM COMPOUNDS
The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates... |
|
|
US20120148661 |
HIGH BIOAVAILABILITY ORAL PICOPLATIN ANTI-CANCER THERAPY
The invention provides a method of treatment of cancer, wherein a individual doses of picoplatin, each of less than about 200 mg picoplatin content, the individual doses having high oral... |
|
|
US20150004102 |
NANOPARTICLES COMPRISING A VEGETABLE HYDROPHOBIC PROTEIN AND A WATER MISCIBLE NON-VOLATILE ORGANIC SOLVENT AND USES THEREOF
The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, said nanoparticles being based on a vegetable hydrophobic protein, particularly zein,... |
|
|
US20140154312 |
ORAL TARGETTED DRUG DELIVERY SYSTEM
The present invention discloses an “Improved Oral Targetted Drug Delivery System (O-TDDS)” particularly suited for delivery of drugs having activity against the diseases located in the colon e.g.... |
|
|
US20150202158 |
GASTRO-RETENTIVE DRUG DELIVERY SYSTEM
The invention relates to floating drug delivery systems(FDDS) that provide solutions to the particular problems often encountered with floating drug delivery systems described in the art. On such... |
|
|
US20140044761 |
HYBRID FRAGRANCE ENCAPSULATE FORMULATION AND METHOD FOR USING THE SAME
A hybrid encapsulate formulation obtained by mixing a starch/fragrance emulsion with a core-shell capsule suspension is provided as is a method of using the formulation in a personal care product,... |
|
|
US20150140085 |
FORMULATIONS COMPRISING IBRUTINIB
Oral pharmaceutical formulations of ibrutinib and/or a pharmaceutically acceptable salt thereof, methods for their administration, process of their production, and use of these formulations for... |
|
|
US20130017257 |
DRY POWDER FORMULATION CONTAINING TIOTROPIUM FOR INHALATION
The present invention is related to a dry powder formulation containing tiotropium to be administered via inhalation, the use of said formulation in the treatment of respiratory diseases... |
|
|
US20140271836 |
MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour... |
|
|
US20130251792 |
ENCAPSULATION OF HEAT AND MOISTURE SENSITIVE SUBSTANCES
The present invention relates to a method for preparing a suspension for the encapsulation of heat and moisture sensitive substances in capsules, sachets, droplets and food compositions. It also... |
|
|
US20140242160 |
CALCIUM SUPPLEMENT
An oral dosage form for administration to an animal comprising a biologically utilizable form of calcium and an extended release system that maintains the calcium level in the animal's bloodstream... |
|
|
US20100255084 |
Medicinal melting capsules for oral mucosal absorption
A medicinal melting capsule comprised of a material that has the same melting point as the human body temperature and includes a therapeutic amount of medication for use in treatment of a desired... |
|
|
US20150216810 |
CONTROLLED RELEASE HYDROCODONE FORMULATIONS
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt... |
|
|
US20150216809 |
CONTROLLED RELEASE HYDROCODONE FORMULATIONS
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt... |
|
|
US20110262532 |
Controlled Release Hydrocodone Formulations
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt... |
|
|
US20150209285 |
DRY GRANULATES OF MESOPOROUS SILICA POWDERS
Dry granulates comprising ordered mesoporous silica unloaded or loaded with a biologically active ingredient and optional excipients, wherein the dry granulates have a Carr index that is equal or... |
|
|
US20120141580 |
CAPSULE FORMULATIONS CONTAINING LANTHANUM COMPOUNDS
The present invention includes an oral pharmaceutical capsule comprising a shell, lanthanum carbonate or lanthanum carbonate hydrate, and a lubricant such as talc, wherein the shell encapsulates... |
|
|
US20110123609 |
MULTIPLE UNIT DOSAGE FORM OF NIACIN
A multiple unit dosage form useful for treating or preventing hyperlipidemia and/or atherosclerosis, wherein multiple unit dosage form comprise of a therapeutically effective amount of niacin or... |
|
|
US20110008610 |
ENCAPSULATED WOOD PRESERVATIVES
A method of incorporating biocides into wood or a wood product, the method including the steps of synthesising a plurality of capsules each having an outer shell of polymer and incorporating... |
|
|
US20120294938 |
PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION WITH CONTROLLED ACTIVE INGREDIENT RELEASE IN THE SMALL INTESTINE AND METHOD FOR ITS PRODUCTION
Any pharmaceutical preparation for oral administration with controlled release of active ingredient in the small bowel, on the basis of active ingredient carriers provided with at least one active... |
|
|
US20150098992 |
COMPOSITE FORMULATION COMPRISING MULTI-UNIT SPHEROIDAL TABLET (MUST) ENCAPSULATED IN HARD CAPSULE AND METHOD FOR PREPARING SAME
Provided is a composite formulation comprising multi-unit spheroidal tablets (MUSTs) encapsulated in a hard capsule and a method for preparing same. The inventive hard capsule composite... |
|
|
US20120156286 |
COMPOSITIONS AND METHODS FOR INCREASED DELIVERY OF COENZYME Q10
Disclosed are compositions comprising Coenzyme Q10 and a cetylated fatty acid blend, pharmaceutical formulations comprising the same and methods of increasing the systemic concentration of... |
|
|
US20110206762 |
ORAL PHARMACEUTICAL FORMULATION OF PELUBIPROFEN WITH IMPROVED DISSOLUTION RATE AND STABILITY
Disclosed is an oral pharmaceutical formulation of pelubiprofen which is improved in dissolution rate and stability. As a result of an improvement in the dissolution rate of pelubiprofen, the oral... |
|
|
US20120201876 |
METHOD OF MANAGING HYPERCORTISOLEMIA, HEADACHE DISORDERS, NEUROPATHIC PAIN AND RELATED DISORDERS
The present disclosure relates to treatment and management of Cushing's syndrome, Headache disorders and Neuropathic using a composition comprising asiaticoside and madecasosside optionally along... |
|
|
US20120076855 |
Oral testosterone composition
The composition for oral administration of testosterone to a man who has androgen deficiency and exhibits one or more symptoms of androgen deficiency, comprises testosterone and a mixture of... |
|
|
US20150164819 |
DRUG DELIVERY SYSTEM FOR ADMINISTRATION OF POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES
This invention relates to a drug delivery system for administration of poorly water soluble pharmaceutically active substance, a pharmaceutical composition comprising such a drug delivery system,... |
|
|
US20110014281 |
DRUG DELIVERY SYSTEM FOR ADMINISTRATION OF POORLY WATER SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES
This invention relates to a drug delivery system for administration of poorly water soluble pharmaceutically active substance, a pharmaceutical composition comprising such a drug delivery system,... |
|
|
US20150224059 |
HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a... |
|
|
US20120244215 |
HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a... |
|
|
US20120244216 |
COATED PHARMACEUTICAL CAPSULE DOSAGE FORM
Pharmaceutical compositions in unit dose form comprising a hard or soft capsule containing a fill consisting of one or more inert ingredients, and one or more coatings on the capsule, wherein at... |
|
|
US20140199232 |
Targeted Therapeutic Nanoparticles
Disclosure of methods and compositions related to chemical conjugations to nanoparticles of polysaccharides cross-linked to poloxamers as well as nano-sized colloids comprised of polysaccharides... |
|
|
US20140086847 |
DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE
The invention relates to a dosage form that is thermoshaped without being extruded and that is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking... |
|
|
US20110268792 |
SURFACE ACTIVE PROTEINS AS EXCIPIENTS IN SOLID PHARMACEUTICAL FORMULATIONS
The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture... |
|
|
US20120064153 |
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery. |
|
|
US20130309299 |
THERAPEUTIC DELIVERY SYSTEM
Therapeutic delivery systems are provided which, in a first embodiment, contain a plurality of multiphase capsules in which first and second therapeutic agents are contained in separate phases... |
|
|
US20130142871 |
ORAL DOSAGE FORM OF DEFERASIROX
The invention relates to an oral dosage form containing deferasirox, binder, disintegrant and optionally wicking agent, wherein the introduction of the dosage form into water leads to a suspension... |
|
|
US20120156287 |
Use of Vitelline Protein B as a Microencapsulating Additive
The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide... |
|
|
US20150165026 |
SINGLET OXYGEN-LABILE LINKERS AND METHODS OF PRODUCTION AND USE THEREOF
Activatable compositions that include at least one functional moiety and at least one cleavable linker directly or indirectly linked to the at least one functional moiety are disclosed. The at... |
|
|
US20110045063 |
PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the... |